Shruti Bhat PhD, MBA, Operations Excellence Expert
  • Home
  • About Shruti
  • Books
  • Insights
  • Operational Excellence
  • Research
    • Innovation Management
    • Leading Research and Development
    • Developer's Diary
  • Case Studies
  • Tools
    • Whitepapers
    • Articles >
      • Business Transformation
      • Process Improvement
      • Business Continuity
      • Change Management
      • Digital Transformation
      • Quality Improvement
    • Checklists and Templates
    • Free eBook
    • Videos
  • Blog
  • Engage Shruti
    • Consulting >
      • Operational Excellence Consulting
      • Business Transformation Consulting
      • Innovation Management Consulting
    • Workshops
  • Contact

Dental and Ocular Controlled Release Drug Delivery Systems

5/16/2009

0 Comments

 
II) DENTAL SYSTEMS:

Controlled and sustained drug delivery has recently begun to make an impression in the area of treatment of dental diseases.  Many researchers demonstrated that CRDDS of antimicrobial agents such as chlorhexidine, ofloxacin and metronidazole could effectively treat and prevent peridontitis.

The incidence of dental carries and formation of plaque can also be reduced by CRDDS of fluoride.  Delivery systems used are film forming solutions, polymer inserts, implants and patches.  Since dental diseases are usually chronic, sustained release of therapeutic agents in the oral cavity would obviously be desirable.


III)   OCULAR  SYSTEMS :

The eye is unique in its therapeutic challenges.  An efficient mechanism, that of tears and tear drainage, which quickly eliminates drug solution, makes topical delivery to the eye somewhat different from most other areas of the body.  Usually less than 10% of a topically applied dose is absorbed into the eye, leaving the rest of the dose to potentially absorb into the blood stream resulting in unwanted side effects.  

The goal of most controlled delivery systems is to maintain the drug in the precorneal area and allow its diffusion across the cornea.  Suspensions and ointments, although able to provide some sustaining effect, do not offer the amount of control desired.  Polymeric matrices can often significantly reduce drainage but other newer methods of controlled drug delivery can also be used.


The application of ocular therapy generally includes drugs for glaucoma, artificial tears, and anticancer drugs for intraocular malignancies.  The sustained release of artificial tears has been achieved by hydroxypropylcellulose polymer insert.  However, the best-known application of diffusional therapy in the eye, Ocusert-Pilo. The device is a relatively simple structure with two rate-controlling membranes surrounding the drug reservoir containing pilocarpine.  

Thus, a thin, flexible lamellar ellipse is created and serves as a model reservoir device.  The unit is placed in the eye and resides in the lower cul-de-sac, just below the cornea.  Since, the device itself remains in the eye, the drug is released into the tear film.


The advantage of such a device is that it can control intraocular pressure for up to a week.  Further, control is achieved with less drug and hence fewer side effects, since the release of drug is close to zero order.  The system is more convenient, since application is weekly as opposed to the four times a day dosing for pilocarpine solutions.  

This greatly improves patient compliance and assures round-the-clock medication, which is of great importance for glaucoma treatment.  The main disadvantage of the system is that it is often difficult to retain in the eye, and can cause some discomfort.


Another method of delivery of drug to the anterior segment of the eye, which has proved successful, is that of prodrug administration.  Since the corneal surface presents an effective lipoidal barrier, especially to hydrophilic compounds, it seems reasonable that a prodrug that is more lipophilic than the parent drug will be more successful in penetrating this barrier.  

Many drugs have been derivatized for prodrug ocular delivery e.g. timolol, nadolol, pilocarpine, prostaglandin F 2 a , terbulatine, aciclovir, vidarabine and idoxuridine.
 

New sustained release technologies are gaining importance in ocular delivery as in other routes.  Liposomes as drug carriers have achieved enhanced ocular delivery of certain drugs; antibiotics and peptides.  Biodegradable matrix drug delivery of pilocarpine can be achieved with a polymeric dispersion.  

​Implantation of polymers containing endotoxin for neovascularization, gancyclovir, 5-flurouracil and injections of doxorubicin have also resulted in sustained delivery.  However, topical ocular delivery is preferred considerably over implants and injection.
Follow Shruti on Twitter, Facebook, YouTube, LinkedIn
0 Comments

Your comment will be posted after it is approved.


Leave a Reply.

    Shruti Bhat, global leader in business turnaround, operational excellence and continuous improvement
    To contact Dr. Shruti Bhat text or WhatsApp at 1.403.969.6219

    New Book Released!

    Revolutionizing Industries with Lean Six Sigma

    Shruti's YouTube Channel ...

    Picture

    Blog Categories

    All
    3D Printing
    Agile
    Artificial Intelligence
    Automation
    Biotechnology
    Books
    Business Continuity
    Business Turnaround
    Case Studies
    Change Management
    Checklists
    Chemical Industry
    Continuous Improvement
    Design Thinking
    Digitalization
    Drug Delivery
    External News Links
    Hall Of Fame
    Healthcare
    Hoshin Kanri
    HR Development
    Innovation
    Insights
    ISO
    Just In Time
    Kaizen
    Leadership
    LEAN
    Lean Six Sigma
    Life Sciences
    Machine Learning
    Manufacturing
    Medical Devices
    Mistake Proofing
    Motivational Cards
    MSMEs
    Nanotechnology
    Operational Excellence
    Packaging
    Patents
    Personal Products
    Process Improvement
    Product Development
    Productivity Increase
    QbD
    Quality Management
    R&D Leadership
    Robotics
    Service Industry
    Six Sigma
    Strategy
    Supply Chain Logistics
    Telecom Industry
    Templates
    TQM
    Videos
    Voice Of Customer
    Whitepaper
    Workshops

    Shruti's books...

    Picture
    top ten strategic decision-making tools for operational excellence
    shruti bhat, business process management, continuous improvement
    kaizen for pharmaceutcials, medical devices and biotech industry book by Dr Shruti Bhat
    Book on Continuous improvement tools by Dr Shruti Bhat
    kaizen for leaders, continuous process improvement tool to increase profit and organizational excellence by shruti bhat
    kaizen, shruti bhat, continuous improvement, quality, operations management
    how to lead a successful business transformation
    leading organizations through crisis
    emotional intelligence
    how to overcome challenges of creating effective teams
    modular kaizen Vs Blitz kaizen
    How to increase employee engagement as a new boss

Connect with Dr. Shruti Bhat at- ​Twitter, YouTube, LinkedIn​

© Copyright 1992- 2025 Dr. Shruti Bhat ALL RIGHTS RESERVED.
See Terms and Conditions for details on this site usage.
Subscribe to Operational Excellence Academy YouTube Channel
​Subscribe to Operational Excellence Academy YouTube Channel
SHRUTI BHAT, CONTACT
Click to connect.
Created by Macro2Micro Media